Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cogstate Ltd ( (AU:CGS) ) just unveiled an update.
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back program, which involves the repurchase of its ordinary fully paid securities. As of the latest update, the company has bought back a total of 5,571,816 securities, including 56,526 on the previous day. This buy-back initiative is part of Cogstate’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in cognitive science and technology solutions. The company focuses on providing cognitive assessment services and tools, primarily used in clinical trials, academic research, and healthcare settings to measure cognitive function.
Average Trading Volume: 114,507
Technical Sentiment Signal: Buy
Current Market Cap: A$235.5M
See more insights into CGS stock on TipRanks’ Stock Analysis page.